Biotest Aktiengesellschaft (BIO3) — Cash Flow-to-Debt Ratio
Biotest Aktiengesellschaft (BIO3) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2025, meaning its operating cash flow of €-58.10 Million could theoretically repay 0% of its total liabilities (€906.90 Million) in one year. Explore BIO3 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotest Aktiengesellschaft Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Biotest Aktiengesellschaft across 23 annual periods. Also explore BIO3 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Biotest Aktiengesellschaft (2002–2024)
Year-by-year debt coverage analysis for Biotest Aktiengesellschaft. For market capitalisation and broader financial context, see BIO3 market cap.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | €60.90 Million | €903.30 Million | ▲ +2377.3% |
| 2023 | 0.00x | €-2.70 Million | €912.00 Million | ▲ +93.9% |
| 2022 | -0.05x | €-40.50 Million | €831.90 Million | ▼ -203.9% |
| 2021 | 0.05x | €33.90 Million | €723.80 Million | ▲ +293.4% |
| 2020 | -0.02x | €-16.70 Million | €689.70 Million | ▲ +54.5% |
| 2019 | -0.05x | €-33.60 Million | €631.50 Million | ▲ +41.8% |
| 2018 | -0.09x | €-50.00 Million | €547.10 Million | ▼ -268.0% |
| 2017 | 0.05x | €34.30 Million | €630.70 Million | ▼ -52.8% |
| 2016 | 0.12x | €65.90 Million | €572.10 Million | ▲ +66.4% |
| 2015 | 0.07x | €38.10 Million | €550.40 Million | ▲ +435.4% |
| 2014 | -0.02x | €-11.40 Million | €552.40 Million | ▼ -22.0% |
| 2013 | -0.02x | €-7.20 Million | €425.80 Million | ▼ -115.2% |
| 2012 | 0.11x | €34.73 Million | €312.91 Million | ▼ -48.4% |
| 2011 | 0.22x | €72.28 Million | €336.09 Million | ▼ -10.3% |
| 2010 | 0.24x | €77.83 Million | €324.73 Million | ▲ +175.1% |
| 2009 | 0.09x | €31.68 Million | €363.59 Million | ▼ -14.4% |
| 2008 | 0.10x | €34.49 Million | €338.67 Million | ▼ -2.6% |
| 2007 | 0.10x | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €198.12 Million | ▲ +41.5% |
| 2004 | 0.10x | €25.29 Million | €250.31 Million | ▲ +50.9% |
| 2003 | 0.07x | €16.52 Million | €246.69 Million | ▲ +610.6% |
| 2002 | 0.01x | €2.46 Million | €261.20 Million | — |